Real-time enrollment status for this diffuse large b cell lymphoma refractory clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:39 AM UTC
| NCT Number | NCT06789159 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B Cell Lymphoma Refractory |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pierluigi Porcu |
| Last Updated on CT.gov | July 8, 2026 (5 days ago) |
As of July 13, 2026: Clinical trial NCT06789159 is currently recruiting participants. This clinical trial study for diffuse large b cell lymphoma refractory is actively seeking new participants at 1 location across the United States. The study is sponsored by Pierluigi Porcu. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06789159 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06789159 was last updated 5 days ago (July 8, 2026). HelloStudys verifies this status automatically.